Micrometer-sized titanium particles can induce potent Th2-type responses through TLR4-independent pathways

Journal of Immunology

Volumn 187, Issue 12, 2011, Pages 6491-6498

  Mishra, Pankaj K ^a   Wu, Wenhui ^a   Rozo, Cristina ^a   Hallab, Nadim J ^b   Benevenia, Joseph ^a   Gause, William C ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b RUSH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 4; OVALBUMIN; TITANIUM; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ADOPTIVE TRANSFER; ANIMALS; CELL DIFFERENTIATION; FEMALE; INFLAMMATION MEDIATORS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, KNOCKOUT; MICE, TRANSGENIC; OVALBUMIN; PARTICLE SIZE; SIGNAL TRANSDUCTION; TH2 CELLS; TITANIUM; TOLL-LIKE RECEPTOR 4;

EID: 83755178479     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101392     Document Type: Article

References (55)

1. Bi, Y., J. M. Seabold, S. G. Kaar, A. A. Ragab, V. M. Goldberg, J. M. Anderson, and E. M. Greenfield. 2001. Adherent endotoxin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation. J. Bone Miner. Res. 16: 2082-2091. (Pubitemid 32995400)
2. Goldring, S. R., A. L. Schiller, M. Roelke, C. M. Rourke, D. A. O'Neil, and W. H. Harris. 1983. The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J. Bone Joint Surg. Am. 65: 575-584. (Pubitemid 13107113)
3. Greenfield, E. M., M. A. Beidelschies, J. M. Tatro, V. M. Goldberg, and A. G. Hise. 2010. Bacterial pathogen-associated molecular patterns stimulate biological activity of orthopaedic wear particles by activating cognate Toll-like receptors. J. Biol. Chem. 285: 32378-32384.
4. Islam, A. S., M. A. Beidelschies, A. Huml, and E. M. Greenfield. 2011. Titanium particles activate Toll-like receptor 4 independently of lipid rafts in RAW264.7 murine macrophages. J. Orthop. Res. 29: 211-217.
5. Bi, Y., T. O. Collier, V. M. Goldberg, J. M. Anderson, and E. M. Greenfield. 2002. Adherent endotoxin mediates biological responses of titanium particles without stimulating their phagocytosis. J. Orthop. Res. 20: 696-703. (Pubitemid 34822988)
6. Larsen, S. T., M. Roursgaard, K. A. Jensen, and G. D. Nielsen. 2010. Nano titanium dioxide particles promote allergic sensitization and lung inflammation in mice. Basic Clin. Pharmacol. Toxicol. 106: 114-117.
7. Carvalho, L., J. Sun, C. Kane, F. Marshall, C. Krawczyk, and E. J. Pearce. 2009. Review series on helminths, immune modulation and the hygiene hypothesis: mechanisms underlying helminth modulation of dendritic cell function. Immunology 126: 28-34.
8. Anthony, R. M., L. I. Rutitzky, J. F. Urban, Jr., M. J. Stadecker, and W. C. Gause. 2007. Protective immune mechanisms in helminth infection. Nat. Rev. Immunol. 7: 975-987. (Pubitemid 350166058)
9. Maizels, R. M., E. J. Pearce, D. Artis, M. Yazdanbakhsh, and T. A. Wynn. 2009. Regulation of pathogenesis and immunity in helminth infections. J. Exp. Med. 206: 2059-2066.
10. Eisenbarth, S. C., D. A. Piggott, J. W. Huleatt, I. Visintin, C. A. Herrick, and K. Bottomly. 2002. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196: 1645-1651. (Pubitemid 36026476)
11. Piggott, D. A., S. C. Eisenbarth, L. Xu, S. L. Constant, J. W. Huleatt, C. A. Herrick, and K. Bottomly. 2005. MyD88-dependent induction of allergic Th2 responses to intranasal antigen. J. Clin. Invest. 115: 459-467. (Pubitemid 40385488)
12. Schnare, M., G. M. Barton, A. C. Holt, K. Takeda, S. Akira, and R. Medzhitov. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2: 947-950. (Pubitemid 32976167)
13. Gavin, A. L., K. Hoebe, B. Duong, T. Ota, C. Martin, B. Beutler, and D. Nemazee. 2006. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314: 1936-1938. (Pubitemid 46026117)
14. Helmby, H., and R. K. Grencis. 2003. Essential role for TLR4 and MyD88 in the development of chronic intestinal nematode infection. Eur. J. Immunol. 33: 2974-2979. (Pubitemid 37428329)
15. Kerepesi, L. A., J. A. Hess, O. Leon, T. J. Nolan, G. A. Schad, and D. Abraham. 2007. Toll-like receptor 4 (TLR4) is required for protective immunity to larval Strongyloides stercoralis in mice. Microbes Infect. 9: 28-34. (Pubitemid 46149414)
16. Liu, Z., Q. Liu, J. Pesce, J. Whitmire, M. J. Ekkens, A. Foster, J. VanNoy, A. H. Sharpe, J. F. Urban, Jr., and W. C. Gause. 2002. Nippostrongylus brasiliensis can induce B7-independent antigen-specific development of IL-4-producing T cells from naive CD4 T cells in vivo. J. Immunol. 169: 6959-6968. (Pubitemid 36899283)
17. Cho, D. R., A. S. Shanbhag, C. Y. Hong, G. R. Baran, and S. R. Goldring. 2002. The role of adsorbed endotoxin in particle-induced stimulation of cytokine release. J. Orthop. Res. 20: 704-713. (Pubitemid 34822989)
18. Smith, R. A., and N. J. Hallab. 2010. In vitro macrophage response to polyethylene and polycarbonate-urethane particles. J. Biomed. Mater. Res. A 93: 347-355.
19. Brown, T., Q.-B. Bao, C. M. Agrawal, and N. J. Hallab. 2011. An in vitro assessment of wear particulate generated from NUBAC, a PEEK on PEEK articulating nucleus replacement device: methodology and results from a series of wear tests using different motion profiles, test frequencies and environmental conditions. Spine. DOI: 10.1097/BRS.0b013e31821ac8a0.
20. Kanaji, A., M. S. Caicedo, A. S. Virdi, D. R. Sumner, N. J. Hallab, and K. Sena. 2009. Co-Cr-Mo alloy particles induce tumor necrosis factor alpha production in MLO-Y4 osteocytes: a role for osteocytes in particle-induced inflammation. Bone 45: 528-533.
21. Haskins, K., R. Kubo, J. White, M. Pigeon, J. Kappler, and P. Marrack. 1983. The major histocompatibility complex-restricted antigen receptor on T cells, I: Isolation with a monoclonal antibody. J. Exp. Med. 157: 1149-1169. (Pubitemid 13083697)
22. Liu, Q., Z. Liu, C. T. Rozo, H. A. Hamed, F. Alem, J. F. Urban, Jr., and W. C. Gause. 2007. The role of B cells in the development of CD4 effector T cells during a polarized Th2 immune response. J. Immunol. 179: 3821-3830.
23. Liu, Z., Q. Liu, H. Hamed, R. M. Anthony, A. Foster, F. D. Finkelman, J. F. Urban, Jr., and W. C. Gause. 2005. IL-2 and autocrine IL-4 drive the in vivo development of antigen-specific Th2 T cells elicited by nematode parasites. J. Immunol. 174: 2242-2249. (Pubitemid 40223971)
24. Brewer, J. M., M. Conacher, C. A. Hunter, M. Mohrs, F. Brombacher, and J. Alexander. 1999. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J. Immunol. 163: 6448-6454.
25. Lambrecht, B. N., M. Kool, M. A. Willart, and H. Hammad. 2009. Mechanism of action of clinically approved adjuvants. Curr. Opin. Immunol. 21: 23-29.
26. de Haar, C., I. Hassing, M. Bol, R. Bleumink, and R. Pieters. 2006. Ultrafine but not fine particulate matter causes airway inflammation and allergic airway sensitization to co-administered antigen in mice. Clin. Exp. Allergy 36: 1469-1479. (Pubitemid 44674132)
27. H2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat. Med. 12: 955-960.
28. Margevicius, K. J., T. W. Bauer, J. T. McMahon, S. A. Brown, and K. Merritt. 1994. Isolation and characterization of debris in membranes around total joint prostheses. J. Bone Joint Surg. Am. 76: 1664-1675. (Pubitemid 24372019)
29. Elfick, A. P., S. M. Green, S. Krikler, and A. Unsworth. 2003. The nature and dissemination of UHMWPE wear debris retrieved from periprosthetic tissue of THR. J. Biomed. Mater. Res. A 65: 95-108. (Pubitemid 37517290)
30. Marrack, P., A. S. McKee, and M. W. Munks. 2009. Towards an understanding of the adjuvant action of aluminium. Nat. Rev. Immunol. 9: 287-293.
31. Schubert, C. 2009. Boosting our best shot. Nat. Med. 15: 984-988.
32. Morefield, G. L., A. Sokolovska, D. Jiang, H. HogenEsch, J. P. Robinson, and S. L. Hem. 2005. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 23: 1588-1595. (Pubitemid 40203396)
33. Mbow, M. L., E. De Gregorio, N. M. Valiante, and R. Rappuoli. 2010. New adjuvants for human vaccines. Curr. Opin. Immunol. 22: 411-416.
34. Eisenbarth, S. C., O. R. Colegio, W. O'Connor, F. S. Sutterwala, and R. A. Flavell. 2008. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453: 1122-1126. (Pubitemid 351871731)
35. Li, H., S. Nookala, and F. Re. 2007. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1β and IL-18 release. J. Immunol. 178: 5271-5276. (Pubitemid 46595312)
36. McKee, A. S., M. W. Munks, M. K. L. MacLeod, C. J. Fleenor, N. Van Rooijen, J. W. Kappler, and P. Marrack. 2009. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J. Immunol. 183: 4403-4414.
37. Franchi, L., and G. Núñez. 2008. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1β secretion but dispensable for adjuvant activity. Eur. J. Immunol. 38: 2085-2089.
38. Kool, M., T. Soullié, M. van Nimwegen, M. A. M. Willart, F. Muskens, S. Jung, H. C. Hoogsteden, H. Hammad, and B. N. Lambrecht. 2008. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205: 869-882. (Pubitemid 351549884)
39. Kuroda, E., K. J. Ishii, S. Uematsu, K. Ohata, C. Coban, S. Akira, K. Aritake, Y. Urade, and Y. Morimoto. 2011. Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity 34: 514-526.
40. Flach, T. L., G. Ng, A. Hari, M. D. Desrosiers, P. Zhang, S. M. Ward, M. E. Seamone, A. Vilaysane, A. D. Mucsi, Y. Fong, et al. 2011. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat. Med. 17: 479-487.
41. Amsen, D., J. M. Blander, G. R. Lee, K. Tanigaki, T. Honjo, and R. A. Flavell. 2004. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117: 515-526. (Pubitemid 38610236)
42. Saenz, S. A., M. Noti, and D. Artis. 2010. Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. Trends Immunol. 31: 407-413.
43. Kreider, T., R. M. Anthony, J. F. Urban, Jr., and W. C. Gause. 2007. Alternatively activated macrophages in helminth infections. Curr. Opin. Immunol. 19: 448-453. (Pubitemid 47299196)
44. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
45. Edwards, J. P., X. Zhang, K. A. Frauwirth, and D. M. Mosser. 2006. Biochemical and functional characterization of three activated macrophage populations. J. Leukoc. Biol. 80: 1298-1307. (Pubitemid 44904968)
46. Haskó, G., P. Pacher, E. A. Deitch, and E. S. Vizi. 2007. Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol. Ther. 113: 264-275. (Pubitemid 46149045)
47. Looney, R. J., E. M. Schwarz, A. Boyd, and R. J. O'Keefe. 2006. Periprosthetic osteolysis: an immunologist's update. Curr. Opin. Rheumatol. 18: 80-87. (Pubitemid 43740409)
48. Bullough, P. G., E. F. DiCarlo, K. K. Hansraj, and M. C. Neves. 1988. Pathologic studies of total joint replacement. Orthop. Clin. North Am. 19: 611-625.
49. Koulouvaris, P., K. Ly, L. B. Ivashkiv, M. P. Bostrom, B. J. Nestor, T. P. Sculco, and P. E. Purdue. 2008. Expression profiling reveals alternative macrophage activation and impaired osteogenesis in periprosthetic osteolysis. J. Orthop. Res. 26: 106-116.
50. Zhu, J., J. Cote-Sierra, L. Guo, and W. E. Paul. 2003. Stat5 activation plays a critical role in Th2 differentiation. Immunity 19: 739-748. (Pubitemid 37490798)
51. Paul, W. E., and J. Zhu. 2010. How are TH2-type immune responses initiated and amplified? Nat. Rev. Immunol. 10: 225-235.
52. Goodridge, H. S., F. A. Marshall, K. J. Else, K. M. Houston, C. Egan, L. Al-Riyami, F. Y. Liew, W. Harnett, and M. M. Harnett. 2005. Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J. Immunol. 174: 284-293. (Pubitemid 40007415)
53. Harn, D. A., J. McDonald, O. Atochina, and A. A. Da'dara. 2009. Modulation of host immune responses by helminth glycans. Immunol. Rev. 230: 247-257.
54. Iwasaki, A., and R. Medzhitov. 2010. Regulation of adaptive immunity by the innate immune system. Science 327: 291-295.
55. Fujishiro, T., D. J. Moojen, N. Kobayashi, W. J. Dhert, and T. W. Bauer. 2011. Perivascular and diffuse lymphocytic inflammation are not specific for failed metal-on-metal hip implants. Clin. Orthop. Relat. Res. 469: 1127-1133.